Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02400359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Mar 2026 to Jun 2027v14
  2. Primary and study completion dates: Dec 2024 to Mar 2026v13
  3. Primary and study completion dates: Mar 2024 to Dec 2024v12
  4. Primary completion date: Oct 2023 to Mar 2024 Completion date: Dec 2023 to Mar 2024v11 Show 1 more changeShow less
    • Completion date: Dec 2023 to Mar 2024
  5. Primary completion date: Oct 2021 to Oct 2023 Completion date: Dec 2021 to Dec 2023v10 Show 1 more changeShow less
    • Completion date: Dec 2021 to Dec 2023
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Oct 2020 to Oct 2021 Completion date: Dec 2020 to Dec 2021v9 Show 1 more changeShow less
    • Completion date: Dec 2020 to Dec 2021
  2. 2 versions Re-verified since Nov 1, 2018, no change to tracked fieldsv7-v8
  3. Primary completion date: Oct 2017 to Oct 2020 Completion date: Dec 2018 to Dec 2020v6 Show 1 more changeShow less
    • Completion date: Dec 2018 to Dec 2020
  4. Re-verified, no change to tracked fieldsv5
  5. Primary completion date: Oct 2016 to Oct 2017 Primary endpoints: 2 to 1 · Completion date: Dec 2018 · Secondary endpoints: 3 to 2v4 Show 3 more changesShow less
    • Primary endpoints: 2 to 1
    • Completion date: Dec 2018
    • Secondary endpoints: 3 to 2

    See this version in full on ClinicalTrials.gov ↗

  6. Re-verified, no change to tracked fieldsv3
  7. Trial status: Recruiting to Active, Not Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this protocol is to investigate, using functional magnetic resonance imaging (fMRI), the effect of treatment with lorcaserin on centers of the brain that control appetite and food intake, as well as lorcaserin's downstream metabolic effects.
Trial Details
NCT Number NCT02400359
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Obesity, Weight Loss
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov